Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.4436
+0.0212 (5.02%)
At close: May 22, 2026, 4:00 PM EDT
0.4512
+0.0076 (1.71%)
Pre-market: May 26, 2026, 4:02 AM EDT
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $21.56 million as of May 22, 2026. Its market cap has decreased by -44.78% in one year.
Market Cap
21.56M
Enterprise Value
-16.07M
1-Year Change
-44.78%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $21.56M, a decrease of -95.11%. That is a compound annual growth rate of -44.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 21.56M | -29.89% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensei Biotherapeutics | 23.87M |
| Pluri | 23.86M |
| Pasithea Therapeutics | 23.38M |
| Marker Therapeutics | 23.34M |
| Traws Pharma | 22.57M |
| VYNE Therapeutics | 22.37M |
| Akari Therapeutics, | 20.91M |
| CEL-SCI | 20.58M |